Prolynx LLC
🇺🇸United States
A Phase I Study of PLX038 in Patients With Advanced Solid Tumors
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- ProLynx LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02646852
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath